Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IGF-I | 100 | ug/mL | 3 | GM-CSF | 177.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 198.0 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 173.0 | 47 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 191.0 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 208.0 | 78 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 193.0 | 48 | |
RA2159 | 3 | GM-CSF | 181.0 | 65 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | GM-CSF | 185.0 | 67 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 169.0 | 46 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 195.5 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 178.0 | 82 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 179.0 | 80 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | GM-CSF | 185.5 | 76 | |
N2586 | 3 | GM-CSF | 182.0 | 70 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | GM-CSF | 192.5 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 181.0 | 48 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 168.0 | 45 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 184.0 | 49 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 147.5 | 62 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 153.0 | 39 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | GM-CSF | 180.0 | 69 | ||||
N2586 | EGF | 100 | ng/mL | 3 | GM-CSF | 194.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 193.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 181.5 | 58 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GM-CSF | 188.0 | 73 |